164 related articles for article (PubMed ID: 8422456)
21. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region.
Flenghi L; Bigerna B; Fizzotti M; Venturi S; Pasqualucci L; Pileri S; Ye BH; Gambacorta M; Pacini R; Baroni CD; Pescarmona E; Anagnostopoulos I; Stein H; Asdrubali G; Martelli MF; Pelicci PG; Dalla-Favera R; Falini B
Am J Pathol; 1996 May; 148(5):1543-55. PubMed ID: 8623923
[TBL] [Abstract][Full Text] [Related]
22. Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms.
Zutter M; Hockenbery D; Silverman GA; Korsmeyer SJ
Blood; 1991 Aug; 78(4):1062-8. PubMed ID: 1868240
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
[TBL] [Abstract][Full Text] [Related]
24. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia.
Hanada M; Delia D; Aiello A; Stadtmauer E; Reed JC
Blood; 1993 Sep; 82(6):1820-8. PubMed ID: 8104532
[TBL] [Abstract][Full Text] [Related]
25. Expression of LAZ3/BCL6 in follicular center (FC) B cells of reactive lymph nodes and FC-derived non-Hodgkin lymphomas.
Bajalica-Lagercrantz S; Piehl F; Lagercrantz J; Lindahl J; Weber G; Kerckeart JP; Porwit-MacDonald A; Nordenskjöld M
Leukemia; 1997 Apr; 11(4):594-8. PubMed ID: 9096701
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 protein in centrocytic lymphoma; a paraffin section study.
Swerdlow SH; Utz GL; Williams ME
Leukemia; 1993 Sep; 7(9):1456-8. PubMed ID: 8371594
[TBL] [Abstract][Full Text] [Related]
27. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.
Pezzella F; Tse AG; Cordell JL; Pulford KA; Gatter KC; Mason DY
Am J Pathol; 1990 Aug; 137(2):225-32. PubMed ID: 2201196
[TBL] [Abstract][Full Text] [Related]
28. [Hodgkin lymphomas ar negative with regard to bcl-2/JH gene rearrangement, but partly express BCL-2 protein: analysis of 83 cases from the German Hodgkin Trial].
Nolte M; Werner M; von Wasielewski R; Wilkens L; Fischer R; Hübner K; Georgii A
Verh Dtsch Ges Pathol; 1994; 78():329-33. PubMed ID: 7534007
[TBL] [Abstract][Full Text] [Related]
29. Expression of human 8-oxoguanine DNA glycosylase (hOGG1) in follicular lymphoma.
Sheehan AM; McGregor DK; Patel A; Shidham V; Fan CY; Chang CC
Mod Pathol; 2005 Nov; 18(11):1512-8. PubMed ID: 16056251
[TBL] [Abstract][Full Text] [Related]
30. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.
Cerroni L; Volkenandt M; Rieger E; Soyer HP; Kerl H
J Invest Dermatol; 1994 Feb; 102(2):231-5. PubMed ID: 8106752
[TBL] [Abstract][Full Text] [Related]
31. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts.
Onizuka T; Moriyama M; Yamochi T; Kuroda T; Kazama A; Kanazawa N; Sato K; Kato T; Ota H; Mori S
Blood; 1995 Jul; 86(1):28-37. PubMed ID: 7795234
[TBL] [Abstract][Full Text] [Related]
32. bcl-2 gene rearrangement in salivary gland lymphoma.
Kerrigan DP; Irons J; Chen IM
Am J Surg Pathol; 1990 Dec; 14(12):1133-8. PubMed ID: 2252103
[TBL] [Abstract][Full Text] [Related]
33. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
[TBL] [Abstract][Full Text] [Related]
34. Follicular center cell lymphoma with the t(14;18) translocation in which the rearranged BCL-2 gene is silent.
Wang J; Raffeld M; Medeiros LJ; Longo DL; Jaffe ES; Duffey P; Stetler-Stevenson M
Leukemia; 1993 Nov; 7(11):1834-9. PubMed ID: 7694006
[TBL] [Abstract][Full Text] [Related]
35. Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines.
Steube KG; Jadau A; Teepe D; Drexler HG
Leukemia; 1995 Nov; 9(11):1841-6. PubMed ID: 7475272
[TBL] [Abstract][Full Text] [Related]
36. Bcl-2 expression in the thymus and periphery.
Fujii Y; Okumura M; Takeuchi Y; Inada K; Nakahara K; Matsuda H; Tsujimoto Y
Cell Immunol; 1994 May; 155(2):335-44. PubMed ID: 8181070
[TBL] [Abstract][Full Text] [Related]
37. Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1.
Denyssevych T; Lestou VS; Knesevich S; Robichaud M; Salski C; Tan R; Gascoyne RD; Horsman DE; Mayer LD
Leukemia; 2002 Feb; 16(2):276-83. PubMed ID: 11840295
[TBL] [Abstract][Full Text] [Related]
38. Expression of HOXC4, HOXC5, and HOXC6 in human lymphoid cell lines, leukemias, and benign and malignant lymphoid tissue.
Bijl J; van Oostveen JW; Kreike M; Rieger E; van der Raaij-Helmer LM; Walboomers JM; Corte G; Boncinelli E; van den Brule AJ; Meijer CJ
Blood; 1996 Mar; 87(5):1737-45. PubMed ID: 8634419
[TBL] [Abstract][Full Text] [Related]
39. Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients.
Aster JC; Kobayashi Y; Shiota M; Mori S; Sklar J
Am J Pathol; 1992 Aug; 141(2):291-9. PubMed ID: 1497088
[TBL] [Abstract][Full Text] [Related]
40. Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
Br J Haematol; 1996 Mar; 92(3):647-52. PubMed ID: 8616030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
